These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28459733)

  • 41. Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%.
    Knibbe CA; Zuideveld KP; DeJongh J; Kuks PF; Aarts LP; Danhof M
    Clin Pharmacol Ther; 2002 Dec; 72(6):670-84. PubMed ID: 12496748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of a pharmacokinetic and pharmacodynamic model for intranasal administration of midazolam in older adults: a single-site two-period crossover study.
    Barends C; den Daas I; Driesens M; Visser A; Absalom A; Colin P
    Br J Anaesth; 2023 Aug; 131(2):284-293. PubMed ID: 37268446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part II. Pharmacodynamics of Electroencephalogram Effects.
    Eisenried A; Schüttler J; Lerch M; Ihmsen H; Jeleazcov C
    Anesthesiology; 2020 Apr; 132(4):652-666. PubMed ID: 31972657
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
    Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics and safety study of posaconazole intravenous solution administered peripherally to healthy subjects.
    Kersemaekers WM; van Iersel T; Nassander U; O'Mara E; Waskin H; Caceres M; van Iersel ML
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1246-51. PubMed ID: 25512407
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monoclonal antibody TB-403: a first-in-human, Phase I, double-blind, dose escalation study directed against placental growth factor in healthy male subjects.
    Martinsson-Niskanen T; Riisbro R; Larsson L; Winstedt L; Stenberg Y; Pakola S; Stassen JM; Glazer S
    Clin Ther; 2011 Sep; 33(9):1142-9. PubMed ID: 21906811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monitored anesthesia care with dexmedetomidine: a prospective, randomized, double-blind, multicenter trial.
    Candiotti KA; Bergese SD; Bokesch PM; Feldman MA; Wisemandle W; Bekker AY;
    Anesth Analg; 2010 Jan; 110(1):47-56. PubMed ID: 19713256
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravenous Ganaxolone: Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability in Healthy Adults.
    Gasior M; Husain A; Barra ME; Raja SM; MacLeod D; Guptill JT; Vaitkevicius H; Rybak E
    Clin Pharmacol Drug Dev; 2024 Mar; 13(3):248-258. PubMed ID: 38231434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety, tolerability and pharmacokinetics of MCI-186 in patients with acute ischemic stroke: new formulation and dosing regimen.
    Kaste M; Murayama S; Ford GA; Dippel DW; Walters MR; Tatlisumak T;
    Cerebrovasc Dis; 2013; 36(3):196-204. PubMed ID: 24135530
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial.
    Glund S; Stangier J; Schmohl M; Gansser D; Norris S; van Ryn J; Lang B; Ramael S; Moschetti V; Gruenenfelder F; Reilly P; Kreuzer J
    Lancet; 2015 Aug; 386(9994):680-90. PubMed ID: 26088268
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses.
    Moore KH; Hussey EK; Shaw S; Fuseau E; Duquesnoy C; Pakes GE
    Cephalalgia; 1997 Jun; 17(4):541-50. PubMed ID: 9209776
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and Tolerability of Intravenous Valproic Acid in Healthy Subjects: A Phase I Dose-Escalation Trial.
    Georgoff PE; Nikolian VC; Bonham T; Pai MP; Tafatia C; Halaweish I; To K; Watcharotone K; Parameswaran A; Luo R; Sun D; Alam HB
    Clin Pharmacokinet; 2018 Feb; 57(2):209-219. PubMed ID: 28497259
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects.
    Christopher R; Covington P; Davenport M; Fleck P; Mekki QA; Wann ER; Karim A
    Clin Ther; 2008 Mar; 30(3):513-27. PubMed ID: 18405789
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics, safety, and tolerability of ascending single intravenous doses of oritavancin administered to healthy human subjects.
    Bhavnani SM; Owen JS; Loutit JS; Porter SB; Ambrose PG
    Diagn Microbiol Infect Dis; 2004 Oct; 50(2):95-102. PubMed ID: 15474317
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Two single-center, double-blind, randomized, placebo-controlled, phase I studies to investigate the tolerability and pharmacokinetics of CH-1504, an antifolate, in healthy male subjects.
    Mant T; Jurcevic S; Szakacs C; Adams L; Boland J; Hewitt LA
    Clin Ther; 2008 Jan; 30(1):131-42. PubMed ID: 18343249
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomized, double-blind, placebo-controlled, single intravenous dose-escalation study to evaluate the safety, tolerability, and pharmacokinetics of the novel coronary smooth muscle cell proliferation inhibitor Biolimus A9 in healthy individuals.
    Steudel W; Dingmann C; Zhang YL; Bendrick-Peart J; Clavijo C; Shulze J; Betts R; Christians U
    J Clin Pharmacol; 2011 Jan; 51(1):29-39. PubMed ID: 20305057
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacodynamic and pharmacokinetic profile of SM-1, a triple-drug combination to increase total sleep time.
    Dahl T; Chen LB; Scheinin M; Suopanki-Lalowski J; Valge M; Puhakka A; Mikola H; Lovró Z; Meierjohann A; Vuorilehto L; Roth T
    Hum Psychopharmacol; 2019 Nov; 34(6):e2716. PubMed ID: 31794072
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sedation Effects Produced by a Ciprofol Initial Infusion or Bolus Dose Followed by Continuous Maintenance Infusion in Healthy Subjects: A Phase 1 Trial.
    Hu C; Ou X; Teng Y; Shu S; Wang Y; Zhu X; Kang Y; Miao J
    Adv Ther; 2021 Nov; 38(11):5484-5500. PubMed ID: 34559359
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Electroencephalographic and hypnotic recoveries after brief and prolonged infusions of etomidate and optimized soft etomidate analogs.
    Ge R; Pejo E; Husain SS; Cotten JF; Raines DE
    Anesthesiology; 2012 Nov; 117(5):1037-43. PubMed ID: 22929726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.